ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Blue Star granted 6,520 stock options to an employee under its ESOP 2024 scheme. Options vest over four years at ₹2 per option.
Blue Star Limited announced record dates for the maturity of listed Commercial Papers totaling Rs. 200 Crore. Redemption is scheduled across three tranches in November 2026.
Blue Star's Dubai Court of Appeal dismissed WJT's application to annul the arbitration award in the company's favour. WJT may still appeal the award.
Management is prioritizing margin recovery over market share following a disappointing Q1. While RAC volumes surged, inability to fully pass on 18% raw material inflation continues to depress segment margins.
Q2FY27 revenue ₹2,931 cr (+21%), PAT ₹124 cr (+25%, incl. ₹23 cr MedTech exit gain); EBITDA +10.5%, margins squeezed in Unitary and projects.
Blue Star Ltd appointed Mr Nithianand S and Mr Senthil Thangam as Senior Management Personnel effective November 1, 2026. This is a leadership change disclosed under Regulation 30.
Blue Star's Q2FY27 consolidated revenue rose 21% to Rs 2,930.95 crore, with operating profit up 10.5%. The press release highlights margin pressure from material cost increases.
Blue Star Ltd reported revenue from operations of ₹2,931 Cr (+21.0% YoY) and net profit of ₹123.9 Cr (+25.4% YoY) for Q2 FY27.
Blue Star Ltd declared the voting results of its postal ballot, announcing the appointment of Mr. Nikhilesh Panchal as an Independent Director of the company.
Blue Star Ltd has initiated the voluntary strike-off of its step-down subsidiary, Blue Star Air Conditioning & Refrigeration (U) Limited, which has not commenced business operations.
Blue Star Limited has filed the certificate from its Registrar and Share Transfer Agent confirming compliance with Regulation 74(5) of SEBI (DP) Regulations, 2018.
Blue Star Limited certified that its Commercial Paper proceeds for the quarter were utilized for working capital purposes. The company confirmed compliance with SEBI listing conditions.
Blue Star Ltd will hold a board meeting on October 29, 2026. The board will consider and approve Q2 and half-year financial results.
Blue Star Limited has issued a Postal Ballot notice seeking shareholder approval for the appointment of Mr. Nikhilesh Panchal as an Independent Director.
Blue Star Limited informed that W.J. Towell & Co LLC has filed an annulment petition in the Dubai Court of Appeal challenging a prior favourable arbitration award.
Blue Star Limited has fixed September 18, 2026, as the record date for its listed Commercial Paper. The maturity amount for this security is Rs. 100 Crores.
Blue Star Limited completed the slump sale of its MedTech division, housed under subsidiary Blue Star E&E, to Cyrix Healthcare for Rs 40 Crore.
Blue Star’s subsidiary, Blue Star E&E, signed a Business Transfer Agreement to sell its MedTech division to Cyrix Healthcare for up to ₹40 Crore.